you are viewing a single comment's thread.
"Those buyers" do not exist... The company has very little cash remaining, but probably enough for the hndful of employees left to pack up and complete the bankruptcy.There is no product whatsoever, pipeline, R&D, phase III, or otherwise. No FDA review either - the 2009 results are final - placebo is as good as the device.A previous post about an alleged "diabetes study" is bogus, along with the study itself.
Then why did they hire Canaccord Adams for 75k per week over the past month?People don't spend 300k for nothign when they are 'about to go bankrupt'
Bankruptcy is very expensive. Arthur Andersen paid in the vicinity of 860 MILLION DOLLARS overall for their bankruptcy filing.Cannacord Adams is a firm which consults in BK matters as well, among company sales, consolidations, etc. And that is a fact sustained by their record.I am sorry I cannot be optimistic on ETRM. I have a $1.22 average price and quite a few shares - holding the bag like many others, though still in the green overall for 2009, portfolio-wise.
dont listen to this bankrupcy jackass.he cant read a balance sheet.